RMP
PRCT icon

Richards, Merrill & Peterson’s Procept Biorobotics PRCT Stock Holding History

Richards, Merrill & Peterson’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-300
Closed -$17.5K – 407
2025
Q1 		$17.5K Buy
+300
New +$20.5K 0.01% 352

Other funds holding PRCT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Richards, Merrill & Peterson's PRCT Position: Q2 2025 in Review

Richards, Merrill & Peterson sold out of Procept Biorobotics (PRCT) in Q2 2025, closing a stake of 300 shares — an estimated $17.5K sold.

Richards, Merrill & Peterson first reported a position in PRCT in Q1 2025 and held it in 1 quarter. The position peaked at $17.5K in Q1 2025. 271 funds tracked by Wall St. Rank hold PRCT as of Q2 2025.

  • Richards, Merrill & Peterson reported no remaining Procept Biorobotics position as of Q2 2025 after selling out during the quarter.
  • Richards, Merrill & Peterson sold 300 Procept Biorobotics shares in Q2 2025, an estimated $17.5K.
  • Richards, Merrill & Peterson first reported a position in Procept Biorobotics in Q1 2025 and held it in 1 quarter.
  • Richards, Merrill & Peterson's Procept Biorobotics position peaked at $17.5K in Q1 2025.
  • 271 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2025.

Based on Richards, Merrill & Peterson's 13F filing for Q2 2025, filed 31 Jul 2025.